2019 Jiangsu Province High-value Patent Cultivation Project

In order to build a strong province with intellectual property rights, Jiangsu Province has successively introduced intellectual property-related policies. How to use innovative intelligence to drive business decisions, how companies can use technology transfer to find a broad blue ocean for survival, and how to cultivate and evaluate high-value patents has also become a hot topic in the industry. topic of. Jiangsu Enhua Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the development, production, and sales of central nervous system drugs. It is the only company in the domestic pharmaceutical industry that focuses on the central nervous system drug market segment. It is a national key high-tech enterprise, a national technological innovation demonstration enterprise, and a national intellectual property demonstration enterprise.

Beijing Huaihai Intellectual Property Agency and Jiangsu Enhua Pharmaceutical Co., Ltd. jointly established the Xuzhou High-Value Patent Cultivation Demonstration Center in 2018, and successfully approved the Jiangsu Province High-Value Patent Cultivation Project in 2019. The project will focus on central nervous compounds and intermediates, preparation, and process methods, deepen the collaborative innovation of industry, university and research, integrate various innovative resources, break through key core technologies, and cultivate a group of highly competitive, forward-looking, and capable leaders The high-value patents of industrial development promote the central nervous drug industry to climb to the high end of the value chain, promote the development of enterprises to intellectual property-intensive industries, and enhance the strength of the industry in international competition.